NCT04803045 is a clinical trial of Follow up email in Infertility, sponsored by Boston IVF.

Who is sponsoring NCT04803045?

NCT04803045 is sponsored by Boston IVF.

What drugs are being tested in NCT04803045?

Interventions in NCT04803045: Follow up email.

What condition does NCT04803045 study?

NCT04803045 studies Infertility.

Is NCT04803045 still recruiting?

NCT04803045 is currently completed. Last updated 22 March 2021.

Last reviewed 2021-03-22 · How we verify

NCT04803045

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Does a Brief Intervention Decrease Patient Drop Out Rates?

Completed Last updated 22 March 2021

What this trial tests

trial testing Follow up email in Infertility in 647 participants. Completed in 1 March 2020.

Timeline

1 July 2017

Primary endpoint
1 January 2019

1 March 2020

Quick facts

Lead sponsor	Boston IVF
Status	Completed
Study type	OBSERVATIONAL
Enrollment	647
Start date	1 July 2017
Primary completion	1 January 2019
Estimated completion	1 March 2020
Sites	1 location across United States

Drugs / interventions tested

Follow up email

Conditions studied

Infertility — all drugs for Infertility →

Sponsor

Boston IVF

Who can join

Eligibility, female only, with Infertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to determine a) if a follow-up email to selected patients who had an initial consult with an infertility specialist, but did not return for a second visit, would change return to care behavior and b) why patients had not returned.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Infertility

Currently open trials in the same condition.

NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting

Other Boston IVF trials

Trials by the same sponsor.

NCT04917445 — The Impact of the SPIKES Protocol With IVF Patients · NA · completed
NCT04330066 — Impact of Endometrial Compaction in Euploid Frozen Embryo Transfers · unknown
NCT04206800 — Effect of Ejaculatory Abstinence on Semen Parameters in Male Factor Infertility Patients · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04803045 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Boston IVF
Last refreshed: 22 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04803045.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing